1. Home
  2. NAMS vs ADX Comparison

NAMS vs ADX Comparison

Compare NAMS & ADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • ADX
  • Stock Information
  • Founded
  • NAMS 2019
  • ADX 1840
  • Country
  • NAMS Netherlands
  • ADX United States
  • Employees
  • NAMS N/A
  • ADX N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • ADX Investment Managers
  • Sector
  • NAMS Health Care
  • ADX Finance
  • Exchange
  • NAMS Nasdaq
  • ADX Nasdaq
  • Market Cap
  • NAMS 2.3B
  • ADX 2.4B
  • IPO Year
  • NAMS N/A
  • ADX N/A
  • Fundamental
  • Price
  • NAMS $20.12
  • ADX $22.40
  • Analyst Decision
  • NAMS Strong Buy
  • ADX
  • Analyst Count
  • NAMS 6
  • ADX 0
  • Target Price
  • NAMS $33.80
  • ADX N/A
  • AVG Volume (30 Days)
  • NAMS 634.7K
  • ADX 182.4K
  • Earning Date
  • NAMS 11-06-2024
  • ADX 01-01-0001
  • Dividend Yield
  • NAMS N/A
  • ADX 6.68%
  • EPS Growth
  • NAMS N/A
  • ADX N/A
  • EPS
  • NAMS N/A
  • ADX N/A
  • Revenue
  • NAMS $33,594,000.00
  • ADX N/A
  • Revenue This Year
  • NAMS N/A
  • ADX N/A
  • Revenue Next Year
  • NAMS N/A
  • ADX N/A
  • P/E Ratio
  • NAMS N/A
  • ADX N/A
  • Revenue Growth
  • NAMS 78.77
  • ADX N/A
  • 52 Week Low
  • NAMS $8.90
  • ADX $14.94
  • 52 Week High
  • NAMS $26.35
  • ADX $19.57
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 44.60
  • ADX 57.84
  • Support Level
  • NAMS $19.59
  • ADX $22.20
  • Resistance Level
  • NAMS $25.32
  • ADX $22.63
  • Average True Range (ATR)
  • NAMS 1.44
  • ADX 0.25
  • MACD
  • NAMS -0.32
  • ADX -0.00
  • Stochastic Oscillator
  • NAMS 36.35
  • ADX 78.10

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About ADX Adams Diversified Equity Fund Inc.

Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally-managed closed-end fund. The investment objectives of the company are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It has a diversified equity portfolio which consists of securities of companies from Energy, Consumer Staples, Information Technology, Financials and other sectors.

Share on Social Networks: